Kiniksa Pharmaceuticals L... (KNSA)
NASDAQ: KNSA
· Real-Time Price · USD
35.22
-0.29 (-0.82%)
At close: Sep 05, 2025, 10:06 AM
-0.82% (1D)
| Bid | 25.23 |
| Market Cap | 2.61B |
| Revenue (ttm) | 529.33M |
| Net Income (ttm) | 4.79M |
| EPS (ttm) | 0.05 |
| PE Ratio (ttm) | 704.4 |
| Forward PE | 21.37 |
| Analyst | Buy |
| Ask | 45.28 |
| Volume | 40,774 |
| Avg. Volume (20D) | 758,950 |
| Open | 35.53 |
| Previous Close | 35.51 |
| Day's Range | 35.22 - 35.60 |
| 52-Week Range | 17.82 - 35.60 |
| Beta | 0.20 |
About KNSA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KNSA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KNSA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Kiniksa Pharmaceuticals Ltd. is scheduled to release its earnings on
Oct 28, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+12.32%
Kiniksa Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
4 months ago
+20.54%
Kiniksa Pharmaceuticals shares are trading higher after the company raised its FY25 sales guidance.
